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ABSTRAK
Retinopati pramatang (ROP) adalah penyakit berkaitan dengan pertumbuhan 
saluran darah tidak matang pada bayi berat lahir rendah disebabkan oleh 
kekurangan oksigen pada retina yang sedang dalam pertumbuhan. Keadaan ini 
boleh membawa kepada risiko kebutaan. ROP selalunya terjadi pada kedua-dua 
mata, namun ada juga kes yang menunjukkan kelainan tahap keterukan penyakit 
di antara kedua mata. Kami melaporkan contoh kes yang mempunyai presentasi 
keterukan penyakit yang berbeza di antara kedua matanya dan rawatan ablasi 
retina hanya diberikan pada mata yang teruk sahaja. Kes ini memberi contoh salah 
satu kesan jangka panjang kepada pesakit yang mengalami ROP yang lebih teruk 
di dalam satu mata.
Kata kunci: retinopati pramatang, ambliopia, anisometropia, miopia, fotokoagulasi 
cahaya
ABSTRACT
Retinopathy of prematurity (ROP) is a disorder describing an immature vascularisation 
of a developing retina in low birth weight preterm infants. This condition potentially 
leads to blindness. ROP developed as a response of hypoxia of the eye due to 
incomplete development of the retinal vessels. ROP is commonly reported as 
bilateral disease,a small percentage of infants have asymmetrical changes. We 
report a case of long-term outcome of a asymmetry ROP changes with peripheral 
retinal ablation in a single eye. This particular case demonstrates the possible long-
term outcome of unilaterally treated ROP which could either be due to the severity 
of the disease itself or the treatment she received. It is important to highlight the 
possibility of unequal development of the eye in asymmetrical presentation of ROP. 
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achieved immediately after treatment, 
other ocular morbidities ensue with the 
growth of the infant. Strabismus and 
amblyopia are still being reported as 
the long-term morbidities observed in 
such cases (VanderVeen et al. 2011).
 Immaturity of the retina is described 
on the basis of the area of the avascular 
zone; presence of changes in zone 
1 is associated with the most severe 
form of immature retina, while those 
in zone 3 were the least severe form 
of the incomplete development of the 
retina (Cryotherapy for Retinopathy of 
Prematurity Cooperative Group 1988). 
Plus disease is defined by the presence 
of arterial tortuosity and venous 
dilatation, which are the critical factors 
for evaluating treatment. While the 
threshold for treatment is at least five 
contiguous or eight cumulative sectors 
(clock hours) showing stage 3 ROP in 
zone 1 or II in the presence of plus 
disease (Cryotherapy for Retinopathy of 
Prematurity Cooperative Group 1988).
 Although ROP is commonly 
reported as a bilateral disease, a small 
percentage of infants have asymmetrical 
changes. Hence, the indication of 
treatment may differ and one eye might 
remain untreated. To the best of our 
knowledge, no detailed report has been 
published on the long-term outcome of 
unilateral ROP treatment.We present a 
case demonstrating one of the possible 
long-term outcome in a patient with 
peripheral retinal ablation in a single 
eye for threshold ROP. At the time of 
INTRODUCTION
Although, the management of premature 
infants has improved over the years, the 
long-term morbidity of these infants, 
especially due to conditions such as 
retinopathy of prematurity (ROP), is 
still a great challenge. The risk factors 
for developing ROP are birth weight 
less than 1500gm and prematurity 
of less than 32 weeks (Palmer et al. 
1991). ROP accounts for 3% of all 
cases of childhood blindness (Rahi & 
Cable 2003). ROP occurs as a result of 
hypoxia of the eye due to incomplete 
development of the retinal vessels. The 
severity of the disease is determined 
on the basis of the size of the avascular 
area, amount of abnormal vessels, and 
the presence of the features of plus 
disease that increase the risk of further 
disease progression. Treatment was 
recommended only if threshold criteria 
were met (Palmer et al. 1991).
 The incidence of blindness from 
untreated ROP has been significantly 
reduced by the availability of treatment 
(Hardy et al. 1997). Management 
of peripheral retinal ablation either 
with laser treatment or cryotherapy 
induces rapid regression of abnormal 
vessels and allows for vascularization 
to continue normally towards the 
ora serata. According to the findings 
of the Cryotherapy for Retinopathy 
of Prematurity (CRYO-ROP) study, 
treatment is necessary only for eyes 
with “threshold” disease. Even if 
successful regression of the disease is 
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treatment constitution, the CRYO-ROP 
study was the main treatment guideline.
CASE REPORT
The patient was a baby girl born at 29 
weeks of gestation in 2004 with a birth 
weight of 1500 gm. At birth, the patient 
had respiratory distress syndrome and 
received respiratory support for more 
than three weeks. Her general condition 
improved with the treatment. During 
routine ophthalmologic screening, 
bilateral changes were consistent with 
ROP detected at 34 weeks following 
conception. There were asymmetrical 
changes in both eyes. The patient’s 
left eye fundus revealed changes of 
“threshold” ROP (stage 3 ROP with 
changes for more than 5 clock hours 
and preretinal hemorrhage in zone 
2 with plus disease). However, the 
right eye showed less severe changes 
(stage 2 ROP changes less than 4 clock 
hours in zone 2) with no evidence 
of plus disease. As per the CRYO-
ROP criteria, treatment was indicated 
only in left eye that had threshold 
disease. Therefore, indirect argon laser 
treatment was administered only for 
the left eye. Meanwhile, no treatment 
was administered to the contralateral 
eye with less severe disease and not 
meeting the threshold criteria.
 The infant responded well to the 
treatment, and both eyes showed rapid 
regression of the abnormal vessels. The 
patient was examined every six months 
and evaluated for refractive errors every 
six months. At six months of age, the 
spherical equivalent was found to be 
+0.75 D in both eyes with no evidence 
of squint at the beginning. The patient’s 
myopic changes progressed more 
rapidly in the left eye than in the right 
eye. Myopic changes at 18 months 
of age showed significant differences 
between the two eyes. The spherical 
equivalent of the treated eye was -2.25 
D, while that of the untreated eye was 
only -0.30D. Significant difference 
in refractive error between the two 
eyes putting her at risk to develop 
amblyopia in the future. Patching of the 
good eye which is one of the treatment 
modalities to prevent amblyopia was 
instituted early. However, the patient 
did not comply with this treatment. 
Anisometropia (significant different 
of the refractive error between the 
two eyes) progressed with her age. At 
eight years of age, the myopia in her 
left eye worsen to -6.25D with best-
corrected visual acuity of 6/36, while 
her right eye remained emmetropic 
(no significant refractive error) with 
6/6 vision. Ocular biometry at the age 
of 8 years revealed steeper corneal 
curvature in the left eye,with a longer 
axial length of 24.17mm in the affected 
eye and 21.37mm in the other eye. 
With the resultant anisometropia and 
poor compliance to treatment, the 
patient experienced dense amblyopia 
with subsequent squint of the left eye.
DISCUSSION
In premature infants, prolonged 
exposure to assisted ventilation, which 
may be necessary for survival, is 
often detrimental to the eye, leading 
to conditions such as ROP (Todd et 
al. 1990). ROP is a disease affecting 
the development of the immature 
vasculature of the eyes of premature 
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babies. It presents in various grades 
of severity, ranging from very mild 
disease without any significant visual 
effect or very aggressive disease with 
abnormal vessel proliferation resulting 
in retinal detachment and blindness. 
Asymmetrical presentation of ROP is 
not uncommon; it has been reported 
that the differences in the severity of the 
eyes of the same patient with only one 
eye requiring treatment occurs in up to 
20% of cases (Azad et al. 2010).
 The infant in this case developed 
threshold changes with plus disease 
in the left eye and less severe form of 
ROP without the presence of threshold 
in the fellow eye. Hence, treatment was 
constituted only in the eye meeting the 
threshold criteria in accordance with 
the standard guideline of CRYO-ROP, 
which was the main treatment guideline 
at the time of presentation. Peripheral 
retina laser ablation is the main stay of 
treatment.
 Despite reducing the risk of complete 
blindness, significant refractive error 
particularly myopia (short sighted) 
which may lead to amblyopia is still 
frequently reported in a high proportion 
of treated infants (Al-Gamdhi et al. 
2004). Amblyopia (also known as lazy 
eye) is a condition which involves 
reduced vision in an eye that otherwise 
appears normal, or out of proportion 
to associated anatomical problems 
of the eye. Detecting the condition in 
early childhood increases the chance of 
successful treatment. 
 In this particular case, at the age of 
eight years, the infant was found to 
have a longer axial length in the treated 
eye than in the other eye which may 
explain the significant refractive error 
condition. The mechanisms of myopia 
in infants with ROP are debatable. Most 
experts agree that the myopic effect 
is the result of poor anterior segment 
development in ROP, particularly of the 
lens and cornea (Garcia-Valenzuela & 
Kaufman 2005). At the same time, the 
incidence of myopia in treated infants 
was reported to correlate with increases 
in the stage of ROP, clock hours of 
involvement, number of laser spots, and 
period of regression (Katoch et al. 2011). 
 However, others have also reported 
that the possible effect of treatment 
particularly peripheral retinal ablation 
may interfere with the normal ocular 
development (Ng et al. 2002). Therefore, 
the exact mechanism of myopia in ROP 
with or without treatment is still poorly 
understood.It is always presumed that 
regression of ROP and resumption 
of the normal development of retinal 
vessels will help the patient achieve 
good visual acuity in the future. 
However, obviously regression of the 
disease is not the only determinant 
factor for a good visual outcome. 
 It is important to highlight the 
possibility of unequal development of 
the eye in asymmetrical presentation of 
ROP. The unresolved issues regarding 
the long-term outcome of ocular 
development in ROP patients warrants 
consideration during the planning of 
treatment in asymmetrical cases. Strict 
monitoring of amblyopia treatment 
would help to prevent poor visual 
outcome in such cases. 
CONCLUSION
Asymmetrical presentation of ROP 
and the resultant differences in the 
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treatment regimens for both eyes may 
have different effects on the long-term 
ocular development of the eyes of the 
patient. Although regression of ROP 
after treatment increases the chances of 
achieving a useful level of vision in the 
patient, regular monitoring and strict 
intervention are equally important for 
the management of significant refractive 
error to avoid poor vision in the future.
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